References
- Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer. Chest 2006;130:1211-9. https://doi.org/10.1378/chest.130.4.1211
- Patz EF Jr, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000;343:1627-33. https://doi.org/10.1056/NEJM200011303432208
- Jeong HC, Lee SY, Oh YH, In KH, Kim HG, Yoo SH. An adenocarcinoma of lung with unusual very slow growth: a case report. J Lung Cancer 2006;5:51-4. https://doi.org/10.6058/jlc.2006.5.1.51
- Kwon KD, Kim JH, Kim DY, Choi MH, Choi JH, Shin DW, et al. A case of adenocarcinoma presenting a solitary pulmonary nodule that grows slowly over 10 years. Tuberc Respir Dis 2008;64:318-23. https://doi.org/10.4046/trd.2008.64.4.318
- Yoon BK, Kim EJ, Kim DI, Lee KH, Ryu JS, Kwak SM, et al. A case of adenocarcinoma presenting a solitary pulmonary nodule that showed no growth over 4 years. Tuberc Respir Dis 2005;59:326-9. https://doi.org/10.4046/trd.2005.59.3.326
- Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008;3:781-92. https://doi.org/10.1097/JTO.0b013e31817c9230
- Hasegawa M, Sone S, Takashima S, Li F, Yang ZG, Maruyama Y, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000;73:1252-9. https://doi.org/10.1259/bjr.73.876.11205667
- Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007;242:555-62. https://doi.org/10.1148/radiol.2422052090
- Hillerdal G. Indolent lung cancers: time for a paradigm shift: a review. J Thorac Oncol 2008;3:208-11. https://doi.org/10.1097/JTO.0b013e3181653ce3
- Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-14. https://doi.org/10.1097/JTO.0b013e31812f3c1a
- Joseph WL, Morton DL, Adkins PC. Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease. J Thorac Cardiovasc Surg 1971;61:23-32.
- Aoki T, Nakata H, Watanabe H, Nakamura K, Kasai T, Hashimoto H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol 2000;174:763-8. https://doi.org/10.2214/ajr.174.3.1740763
- Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-16. https://doi.org/10.1093/jnci/92.16.1308
- Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 2007;297:953-61. https://doi.org/10.1001/jama.297.9.953
- Bepler G, Goodridge Carney D, Djulbegovic B, Clark RA, Tockman M. A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Cancer Control 2003;10:306-14. https://doi.org/10.1177/107327480301000405